{"id":237375,"date":"2024-03-26T14:59:47","date_gmt":"2024-03-26T13:59:47","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=237375"},"modified":"2024-03-26T14:59:52","modified_gmt":"2024-03-26T13:59:52","slug":"infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/","title":{"rendered":"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica per a potenciar l\u2019autocura de la poblaci\u00f3"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Els farmac\u00e8utics tenen un paper clau en la prevenci\u00f3 mitjan\u00e7ant l&#8217;assessorament de medicaments i productes de venda lliure que requereixen indicaci\u00f3 farmac\u00e8utica<\/h2>\n\n\n\n<p>La taula titulada <strong>&#8220;Com pot millorar la indicaci\u00f3 farmac\u00e8utica l&#8217;autocura de la salut de la poblaci\u00f3?&#8221; <\/strong>en Infarma Madrid 2024 va comptar amb la participaci\u00f3 de Vicente J. Bauxaul\u00ed, president de SEFAC; Jaume Pey, director general de anefp; i Cristina Mu\u00f1oz Garc\u00eda, farmac\u00e8utica comunit\u00e0ria i delegada de zona del Col\u00b7legi Oficial de Farmac\u00e8utics de Madrid, qui va moderar la sessi\u00f3.<\/p>\n\n\n\n<p><strong>Els farmac\u00e8utics tenen un paper clau en la promoci\u00f3 de la salut i la prevenci\u00f3 mitjan\u00e7ant l&#8217;assessorament de medicaments i productes de venda lliure que requereixen indicaci\u00f3 farmac\u00e8utica<\/strong>. En aquest sentit, es va destacar <strong>l&#8217;oportunitat d&#8217;utilitzar les farm\u00e0cies comunit\u00e0ries per a tractar s\u00edmptomes menors i aix\u00ed alleujar la c\u00e0rrega del Sistema Nacional de Salut<\/strong>.<\/p>\n\n\n\n<p>\u201cL&#8217;autocura despr\u00e9s de la pand\u00e8mia gaudeix d&#8217;un bon estat de salut\u201d, va avan\u00e7ar Jaume Pey. \u00c9s un <strong>mercat emergent<\/strong> que inclou <strong>medicaments sense recepta<\/strong>, <strong>complements de nutrici\u00f3,<\/strong> <strong>dermofarm\u00e0cia<\/strong>, entre altres i que registra<strong> creixements anuals de vendes del 7% <\/strong>en els \u00faltims anys. Encara que en comparaci\u00f3 amb la resta d&#8217;Europa, continua havent-hi una baixa penetraci\u00f3 dels medicaments sense recepta en el mercat espanyol. \u201cTenim un camp de creixement en aquest segment molt important\u201d assegura Pey.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Tractament de s\u00edmptomes menors: una oportunitat per al sistema de salut<\/h3>\n\n\n\n<p>Per al president de SEFAC, Bauxaul\u00ed, cal avan\u00e7ar en <strong>el paper del farmac\u00e8utic en el tractament de s\u00edmptomes menors<\/strong>, com un servei que pot contribuir a <strong>reduir la pressi\u00f3 assistencial del sistema<\/strong>.<\/p>\n\n\n\n<p>Els<strong> medicaments per a tractar el dolor s\u00f3n els que m\u00e9s consultes generen en la farm\u00e0cia<\/strong>. \u201cEl canvi d&#8217;estatus de medicament de prescripci\u00f3 a medicament de no prescripci\u00f3 \u00e9s una opci\u00f3\u201d perqu\u00e8 el farmac\u00e8utic disposi de m\u00e9s possibilitats de tractament.<\/p>\n\n\n\n<p>En aquesta l\u00ednia, el director general de anefp considera que<strong> hi ha espai per a potenciar l&#8217;autocura a trav\u00e9s de la farm\u00e0cia comunit\u00e0ria en malalties com la migranya, la disfunci\u00f3 er\u00e8ctil o la sinusitis<\/strong>, entre altres. Una de les claus \u00e9s que, <strong>quan es produeix un primer diagn\u00f2stic, el medicament pugui passar a l&#8217;autocura<\/strong>. \u201cNecessitem ampliar les indicacions dels medicaments en la l\u00ednia d&#8217;altres pa\u00efsos i que el marc legislatiu ens permeti una major acci\u00f3 farmac\u00e8utica perqu\u00e8 els ciutadans puguin accedir a aquests tractaments de manera lliure\u201d, va reclamar. \u201cUn dels riscos de no fer-ho \u00e9s rec\u00f3rrer a Internet a buscar aquests tractaments\u201d.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Cribratges i productes d&#8217;autotest<\/h3>\n\n\n\n<p>Un altre \u00e0mbit de desenvolupament en la farm\u00e0cia comunit\u00e0ria s\u00f3n els <strong>productes d&#8217;autotest<\/strong>. Els experts emfatitzen la <strong>necessitat d&#8217;un marc legislatiu<\/strong> actualitzat per a recolzar aquesta pr\u00e0ctica. <strong>Els cribratges representen una oportunitat per a les farm\u00e0cies<\/strong>, i s&#8217;advoca per ampliar les compet\u00e8ncies del farmac\u00e8utic en aquest camp. En particular, en el cas de les <strong>infeccions de transmissi\u00f3 sexual<\/strong>.<\/p>\n\n\n\n<p><strong>Font:<\/strong> <strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/www.infarma.es\/\" target=\"_blank\" rel=\"noreferrer noopener\">Infarma 2024<\/a><\/span><\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La taula titulada &#8220;Com pot millorar la indicaci\u00f3 farmac\u00e8utica l&#8217;autocura de la salut de la poblaci\u00f3?&#8221; en Infarma Madrid 2024 va comptar amb la participaci\u00f3 de Vicente J. Bauxaul\u00ed, president de SEFAC; Jaume Pey, director general de anefp; i Cristina Mu\u00f1oz Garc\u00eda, farmac\u00e8utica comunit\u00e0ria i delegada de zona del Col\u00b7legi Oficial de Farmac\u00e8utics de Madrid, qui va moderar la sessi\u00f3.<\/p>\n","protected":false},"author":5,"featured_media":237383,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"<!-- wp:heading {\"textColor\":\"vivid-red\"} -->\n<h2 class=\"wp-block-heading has-vivid-red-color has-text-color\">Qualsevol treballador del sector pot adherir-se lliurement a aquest acord perqu\u00e8 li sigui aplicat l\u2019augment salarial retroactiu de 2023 (4%) i la resta de condicions contemplades a l\u2019acord<\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p><br>El dimarts, 6 de febrer, es va signar un <strong>acord retributiu-salarial i de tancament de 2023 entre l'AFB<\/strong> (Associaci\u00f3 de Farm\u00e0cies de Barcelona) i els <strong>sindicats <\/strong>UGT de Catalunya, CCOO de Catalunya i ASATEF (Associaci\u00f3 Sindical d'Auxiliars, T\u00e8cnics i Empleats de Farm\u00e0cia de Barcelona).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>A l'esmentat acord entre l'empresarial i les <strong>organitzacions sindicals que representen pr\u00e0cticament el 75%<\/strong> dels 11.200 emprats\/es en les farm\u00e0cies de la prov\u00edncia de Barcelona, <strong>no es va sumar AFASCAT<\/strong> (l'Associaci\u00f3 de Farmac\u00e8utics\/es Substituts\/es de Catalunya).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>El tancament de les negociacions per a 2023 sense la signatura d'AFASCAT converteix l'acord en un \"Acord-conveni extratutari\"<\/strong> que no t\u00e9 una efic\u00e0cia general enfront de tots els subjectes representants en la negociaci\u00f3 i en el seu \u00e0mbit funcional, sin\u00f3 que <strong>obliga, \u00fanicament, a les empreses-oficines de farm\u00e0cia associades a l'AFB i als treballadors afiliats als sindicats signants (UGT, CCEOO i ASATEF).<\/strong><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong>No obstant aix\u00f2, legalment, qualsevol treballador del sector pot adherir-se lliurement a aquest acord perqu\u00e8 li sigui aplicat l'augment salarial retroactiu de 2023 (4%) i la resta de condicions contemplades a l'acord,<\/strong> la qual cosa suposa actualitzar autom\u00e0ticament, tamb\u00e9 per 2024, el salari base i altres complements salarials de cada lloc de treball\/nivell professional en el sector.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Podeu consultar els detalls en la circular de l'assessor jur\u00eddic-laboral de l'AFB, Consultor\u00eda y Estudio Legal.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p><strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/02\/Documentacio-completa.-1-2.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Descarregar la documentaci\u00f3 (circular, acord signat i full-model d'adhesi\u00f3)<\/a><\/span><\/em><\/strong><\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\"><strong>Jornada explicativa d'aquest acord<\/strong><\/h3>\n<!-- \/wp:heading -->\n\n<!-- wp:paragraph -->\n<p><strong>L'AFB <\/strong>organitza, el pr\u00f2xim <strong>dilluns, dia 26 de febrer, a les 17.00 hores, <\/strong>una jornada a <strong>Barcelona <\/strong>per explicar als farmac\u00e8utics titulars, siguin socis o no de l'empresarial, en qu\u00e8 consisteix aquest acord per 2023 i resoldre tots els dubtes dels assistents.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:paragraph -->\n<p>Els interessats a assistir poden <strong>resevar pla\u00e7a<\/strong> omplint el<strong><em><a href=\"https:\/\/docs.google.com\/forms\/d\/e\/1FAIpQLSfZko9ufpqC8IIKPJoByMmv9fA_Nr7dWR_7zs_yrDq3IzXKdg\/viewform\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"text-decoration: underline\"> formulari d'inscripci\u00f3.<\/span><\/a><\/em><\/strong><\/p>\n<!-- \/wp:paragraph -->","_et_gb_content_width":"","footnotes":""},"categories":[2066,10,11,12,13,14,15],"tags":[85,918,2274,2696],"class_list":["post-237375","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","tag-fefac","tag-indicacio-farmaceutica","tag-farmacia-2","tag-infarma-2024"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Infarma 2024: la indicaci\u00f3 farmac\u00e8utica i l\u2019autocura de la poblaci\u00f3<\/title>\n<meta name=\"description\" content=\"Els farmac\u00e8utics tenen un paper clau en la prevenci\u00f3 mitjan\u00e7ant l&#039;assessorament de medicaments i productes de venda lliure.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica i l\u2019autocura de la poblaci\u00f3\" \/>\n<meta property=\"og:description\" content=\"Els farmac\u00e8utics tenen un paper clau en la prevenci\u00f3 mitjan\u00e7ant l&#039;assessorament de medicaments i productes de venda lliure.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-26T13:59:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-26T13:59:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/inf24-np-autocuidado-1200x675-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lgallardo@fefac.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lgallardo@fefac.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/\"},\"author\":{\"name\":\"lgallardo@fefac.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\"},\"headline\":\"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica per a potenciar l\u2019autocura de la poblaci\u00f3\",\"datePublished\":\"2024-03-26T13:59:47+00:00\",\"dateModified\":\"2024-03-26T13:59:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/\"},\"wordCount\":536,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/inf24-np-autocuidado-1200x675-1.jpg\",\"keywords\":[\"FEFAC\",\"indicaci\u00f3 farmac\u00e8utica\",\"farmacia\",\"infarma 2024\"],\"articleSection\":[\"Actualitat\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/\",\"name\":\"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica i l\u2019autocura de la poblaci\u00f3\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/inf24-np-autocuidado-1200x675-1.jpg\",\"datePublished\":\"2024-03-26T13:59:47+00:00\",\"dateModified\":\"2024-03-26T13:59:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\"},\"description\":\"Els farmac\u00e8utics tenen un paper clau en la prevenci\u00f3 mitjan\u00e7ant l'assessorament de medicaments i productes de venda lliure.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/inf24-np-autocuidado-1200x675-1.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/inf24-np-autocuidado-1200x675-1.jpg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica per a potenciar l\u2019autocura de la poblaci\u00f3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\",\"name\":\"lgallardo@fefac.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/lucia-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica i l\u2019autocura de la poblaci\u00f3","description":"Els farmac\u00e8utics tenen un paper clau en la prevenci\u00f3 mitjan\u00e7ant l'assessorament de medicaments i productes de venda lliure.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/","og_locale":"ca_ES","og_type":"article","og_title":"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica i l\u2019autocura de la poblaci\u00f3","og_description":"Els farmac\u00e8utics tenen un paper clau en la prevenci\u00f3 mitjan\u00e7ant l'assessorament de medicaments i productes de venda lliure.","og_url":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/","og_site_name":"FEFAC","article_published_time":"2024-03-26T13:59:47+00:00","article_modified_time":"2024-03-26T13:59:52+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/inf24-np-autocuidado-1200x675-1.jpg","type":"image\/jpeg"}],"author":"lgallardo@fefac.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lgallardo@fefac.cat","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/"},"author":{"name":"lgallardo@fefac.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9"},"headline":"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica per a potenciar l\u2019autocura de la poblaci\u00f3","datePublished":"2024-03-26T13:59:47+00:00","dateModified":"2024-03-26T13:59:52+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/"},"wordCount":536,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/inf24-np-autocuidado-1200x675-1.jpg","keywords":["FEFAC","indicaci\u00f3 farmac\u00e8utica","farmacia","infarma 2024"],"articleSection":["Actualitat","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/","url":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/","name":"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica i l\u2019autocura de la poblaci\u00f3","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/inf24-np-autocuidado-1200x675-1.jpg","datePublished":"2024-03-26T13:59:47+00:00","dateModified":"2024-03-26T13:59:52+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9"},"description":"Els farmac\u00e8utics tenen un paper clau en la prevenci\u00f3 mitjan\u00e7ant l'assessorament de medicaments i productes de venda lliure.","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/inf24-np-autocuidado-1200x675-1.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/03\/inf24-np-autocuidado-1200x675-1.jpg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/infarma-2024-indicacio-farmaceutica-potenciar-lautocuidat-la-poblacio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Infarma 2024: la indicaci\u00f3 farmac\u00e8utica per a potenciar l\u2019autocura de la poblaci\u00f3"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9","name":"lgallardo@fefac.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/lucia-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=237375"}],"version-history":[{"count":8,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237375\/revisions"}],"predecessor-version":[{"id":237388,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/237375\/revisions\/237388"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/237383"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=237375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=237375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=237375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}